Contact

All Stories

  1. The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression

    Article • Blood Cancer Journal, April 2024, Springer Science + Business Media

    Dr Albert Oriol, Dr Marta Fernandez-Mercado

  2. Clinical Utility of Individualized Follow-Up in Acute Myeloid Leukemia (AML) Patients Using a Myeloid NGS Panel

    Article • Biomedical Journal of Scientific & Technical Research, October 2023, Biomedical Research Network, LLC

    Dr Marta Fernandez-Mercado

  3. OA-20 Genomic profiling of high-risk smoldering myeloma patients treated with a curative strategy: a biological study of the phase II GEM CESAR clinical trial

    Article • Clinical Lymphoma Myeloma & Leukemia, September 2023, Elsevier

    Dr Marta Fernandez-Mercado

  4. "Whole Exome Sequencing or Pan-Myeloid NGS Gene Panel to Assess Leukemic Evolution of Myelodysplastic Syndromes. Advantages and Disadvantages"

    Article • Biomedical Journal of Scientific & Technical Research, January 2022, Biomedical Research Network, LLC

    Dr Marta Fernandez-Mercado

  5. Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms

    Article • Journal of Clinical Medicine, November 2020, MDPI AG

    Dr Marta Fernandez-Mercado

  6. Identification of Recurrent Mutations in the microRNA-Binding Sites of B-Cell Lymphoma-Associated Genes in Follicular Lymphoma

    Article • International Journal of Molecular Sciences, November 2020, MDPI AG

    Dr Marta Fernandez-Mercado

  7. Strategy for identification of a potential inherited leukemia predisposition in a 299 patient’s cohort with tumor-only sequencing data

    Article • Leukemia Research, August 2020, Elsevier

    Dr Marta Fernandez-Mercado

  8. Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design

    Article • PLOS One, January 2020, PLOS

    Dr Marta Fernandez-Mercado

  9. Strategy for Identification of an Inherited Leukemia Predisposition in a 299 Patients Cohort with Tumor-Only Sequencing Data

    Article • Blood, November 2019, American Society of Hematology

    Dr Marta Fernandez-Mercado

  10. Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia

    Article • British Journal of Haematology, October 2019, Wiley

    FRANCESC SOLE, Dr Marta Fernandez-Mercado

  11. PF220 COMPARISON OF FOUR NGS PANELS AND ANALYSIS OF THEIR CLINICAL UTILITY IN MYELOID HEMATOLOGICAL MALIGNANCIES OF THE MYELOID LINAGE

    Article • HemaSphere, June 2019, Wiley

    Dr Marta Fernandez-Mercado

  12. PF238 TUMOR NGS‐PANEL UTILITY IN THE IDENTIFICATION OF GERMLINE VARIANTS IN MYELOID MALIGNANCIES

    Article • HemaSphere, June 2019, Wiley

    Dr Marta Fernandez-Mercado

  13. PS1008 A NEW NEXT‐GENERATION SEQUENCING STRATEGY FOR THE SIMULTANEOUS DETECTION OF GENE MUTATIONS AND COPY NUMBER VARIATIONS IN MYELOID MALIGNANCIES

    Article • HemaSphere, June 2019, Wiley

    Dr Marta Fernandez-Mercado

  14. PS1146 LOW-COVERAGE WHOLE GENOME SEQUENCING OUTPERFORMS FISH IN COPY NUMBER VARIATION DETECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA

    Article • HemaSphere, June 2019, Wiley

    Dr Marta Fernandez-Mercado

  15. The Circulating Transcriptome as a Source of Biomarkers for Melanoma

    Article • Cancers, January 2019, MDPI AG

    Dr Marta Fernandez-Mercado

  16. The First Dose of Fingolimod Affects Circulating Extracellular Vesicles in Multiple Sclerosis Patients

    Article • International Journal of Molecular Sciences, August 2018, MDPI AG

    Dr Marta Fernandez-Mercado

  17. Mutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinoma

    Article • Scientific Reports, April 2018, Springer Science + Business Media

    Dr Marta Fernandez-Mercado

  18. Spatial intratumoural heterogeneity in the expression of GIT1 is associated with poor prognostic outcome in oestrogen receptor positive breast cancer patients with synchronous lymph node metastases

    Article • F1000Research, August 2017, Faculty of 1000, Ltd.

    Dr Marta Fernandez-Mercado, ISABEL ALVAREZ LOPEZ

  19. Follicular lymphoma cases harbour recurrent mutations in micro-RNA binding sites of genes associated with lymphomagenesis

    Article • European Journal of Cancer, July 2016, Elsevier

    Dr Marta Fernandez-Mercado

  20. Targeted resequencing analysis of 31 genes commonly mutated in myeloid disorders in serial samples from myelodysplastic syndrome patients showing disease progression

    Article • Leukemia, May 2015, Springer Science + Business Media

    Dr Marta Fernandez-Mercado

  21. MicroRNAs as B-cell lymphoma biomarkers

    Article • Blood and Lymphatic Cancer Targets and Therapy, February 2015, Taylor & Francis

    Dr Marta Fernandez-Mercado

  22. Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells

    Article • Leukemia, November 2014, Springer Science + Business Media

    Dr Marta Fernandez-Mercado

  23. Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia

    Article • Leukemia, December 2013, Springer Science + Business Media

    Dr Marta Fernandez-Mercado

  24. Targeted next‐generation sequencing and non‐coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes

    Article • The Journal of Pathology, December 2013, Wiley

    Dr Marta Fernandez-Mercado

  25. Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression

    Article • British Journal of Haematology, July 2013, Wiley

    Dr Marta Fernandez-Mercado

  26. Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes

    Article • Haematologica, July 2013, Ferrata Storti Foundation (Haematologica)

    Dr Marta Fernandez-Mercado

  27. Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34+ progenitor cells

    Article • British Journal of Haematology, January 2013, Wiley

    Dr Marta Fernandez-Mercado

  28. The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts

    Article • Leukemia, October 2012, Springer Science + Business Media

    Dr Marta Fernandez-Mercado

  29. Mutation Patterns of 16 Genes in Primary and Secondary Acute Myeloid Leukemia (AML) with Normal Cytogenetics

    Article • PLOS One, August 2012, PLOS

    Dr Marta Fernandez-Mercado

  30. Effects of L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts

    Article • Leukemia, March 2012, Springer Science + Business Media

    Dr Marta Fernandez-Mercado

  31. TET2 Mutations Are Associated with Specific 5-Methylcytosine and 5-Hydroxymethylcytosine Profiles in Patients with Chronic Myelomonocytic Leukemia

    Article • PLOS One, February 2012, PLOS

    Dr Marta Fernandez-Mercado

  32. Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia

    Article • Leukemia, February 2010, Springer Science + Business Media

    Dr Marta Fernandez-Mercado

  33. Methylation status of SOCS1 and SOCS3 in BCR-ABL negative and JAK2V617F negative chronic myeloproliferative neoplasms

    Article • Leukemia Research, October 2008, Elsevier

    Dr Marta Fernandez-Mercado